-
HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH ENDOMETRIAL CANCER TREATMENT IN THE PUBLIC SETTING IN BRAZIL
Mar 18, 2026, 21:38 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION & ASSOCIATED DRIVERS AMONG PATIENTS WITH OSTEOGENESIS IMPERFECTA
Mar 18, 2026, 21:38 PM -
THE ECONOMIC IMPACT OF METABOLIC SYNDROME IN SCHIZOPHRENIA: A CLAIMS-BASED ANALYSIS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD CTDNA TEST UTILIZATION AND ASSOCIATED COSTS IN US PATIENTS WITH BLADDER CANCER WHO UNDERWENT RADICAL CYSTECTOMY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF IMIPENEM/CILASTATIN/RELEBACTAM FOR CARBAPENEM-NON-SUSCEPTIBLE GRAM-NEGATIVE BACTERIAL INFECTIONS IN CHINA
Mar 18, 2026, 21:38 PM -
ASSOCIATIONS BETWEEN SOCIAL DETERMINANTS OF HEALTH AND OUTCOMES AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Mar 18, 2026, 21:38 PM -
VALUE-BASED PROCUREMENT FOR WOUND CARE MEDICAL DEVICES: INTERNATIONAL FRAMEWORKS, TENDER DESIGN CRITERIA, AND IMPLEMENTATION LEVERS ACROSS HEALTH SYSTEMS
Mar 18, 2026, 21:38 PM -
REAL-WORLD RELIABILITY AND VALIDITY OF THE EQ-5D-5L IN CHINESE PATIENTS WITH DIABETIC KIDNEY DISEASE: A CROSS-SECTIONAL STUDY
Mar 18, 2026, 21:38 PM -
EVALUATING PER-MEMBER-PER-MONTH EXPENDITURE BENCHMARKS IN NON-ONCOLOGY: TARGETED REVIEW IN CANADA
Mar 18, 2026, 21:38 PM -
PREDICTING THE MAXIMUM FAIR PRICE (MFP) FROM THE SECOND ROUND OF MEDICARE NEGOTIATIONS
Mar 18, 2026, 21:38 PM -
ACCESS TO INNOVATIVE AUTOIMMUNE THERAPIES IN LATIN AMERICA: CROSS-COUNTRY EVIDENCE TO INFORM VALUE-BASED DECISION-MAKING
Mar 18, 2026, 21:38 PM -
MACHINE LEARNING MODELS FOR PREDICTING SERIOUS ADVERSE EVENT REPORTS IN GLP-1 RECEPTOR AGONISTS USING FAERS, 2015-2025
Mar 18, 2026, 21:38 PM -
HOSPITAL LENGTH OF STAY AMONG MEDICARE BENEFICIARIES UNDERGOING TRANSCAROTID ARTERY REVASCULARIZATION VERSUS CAROTID ENDARTERECTOMY: A RETROSPECTIVE CLAIMS ANALYSIS
Mar 18, 2026, 21:38 PM -
BLINATUMOMAB FOR FIRST RELAPSE OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-CENTER AMBISPECTIVE COHORT STUDY FROM CARTAGENA, COLOMBIA
Mar 18, 2026, 21:38 PM -
BURDENOFHOSPITALACQUIREDPRESSURE INJURIES(HAPIS)AMONGST HIGH-RISK HOSPITALIZED PATIENTS:AREAL-WORLD ANALYSIS
Mar 18, 2026, 21:38 PM -
DELAYED DIAGNOSIS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) AMONG PATIENTS TREATED WITH TAFAMIDIS
Mar 18, 2026, 21:38 PM -
PRIORITIZING AND COSTING RMNCH INNOVATIONS FOR SCALABLE IMPACT: A COMBINED MCDA AND COSTING APPROACH FROM ETHIOPIA
Mar 18, 2026, 21:38 PM -
MODELLING ASSOCIATIONS BETWEEN EXTREME POVERTY TRAJECTORIES AND POPULATION GROWTH FOR HEALTH SYSTEMS PLANNING
Mar 18, 2026, 21:38 PM -
UPDATED COST-EFFECTIVENESS ANALYSIS OF POLATUZUMAB VEDOTIN COMBINED WITH CHEMOIMMUNOTHERAPY FOR UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN CHINA: EVIDENCE FROM LONG-TERM FOLLOW-UP OF THE POLARIX ASIAN SUBGROUP
Mar 18, 2026, 21:38 PM -
GLOBAL AVAILABILITY AND ACCESS TO EVIDENCE-BASED ANTI-OBESITY PHARMACOTHERAPIES: A SYSTEMATIC ASSESSMENT OF REGULATORY AND REIMBURSEMENT LANDSCAPES
Mar 18, 2026, 21:38 PM
